Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fred Telling Insider Profile
4 Followers
Fred Telling, Director at CTI BioPharma, holds 38.34K shares in Oragenics (Ticker: OGEN), holds ― shares in CTI BioPharma (Ticker: CTIC). Most recently, Fred Telling Sold ― shares of Oragenics on Dec 01, 2023 for an estimated value of 12.46K.
Profitable Transactions
3 out of 9 Profitable Transactions
Average Return
-31.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Fred Telling holds in companies
Most Profitable Insider Trade
The most profitable trade made by Fred Telling
Fred Telling's Trading History
CTI BioPharma
Dec 11, 2015
―
Uninformative Sell
―
―
Oragenics
Dec 01, 2023
Director
Informative Sell
12.46K
$10.74K
List of latest transactions for each holding click on a transaction to see Fred Telling's performance on stock
You May Also Like
Fred Telling insider profile FAQ
What is the percentage of profitable transactions made by Fred Telling?
The percentage of profitable transactions made by Fred Telling is 33%.
What is the average return per transaction made by Fred Telling?
The average return per transaction made by Fred Telling is -31.20%.
What stocks does Fred Telling hold?
Fred Telling holds: CTIC, OGEN stocks.
What was Fred Telling’s latest transaction?
Fred Telling latest transaction was an Informative Sell of $12.46K.
What was Fred Telling's most profitable transaction?
Fred Telling’s most profitable transaction was an Informative Sell of OGEN stock on December 1, 2023. The return on the trade was 88.80%.
What is Fred Telling's role in CTI BioPharma?
Fred Telling's role in CTI BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.